Last reviewed · How we verify

NCT03505463

The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury

Status unknown Last updated 13 November 2020
What this trial tests

trial testing Blood samples in Spinal Cord Injury, Acute in 30 participants. Status unknown.

Timeline
1 May 2018
Primary endpoint
1 December 2020
1 December 2020

Quick facts

Lead sponsorUniversity of Aarhus
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 May 2018
Primary completion1 December 2020
Estimated completion1 December 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

Adults 18 to 70, any sex, with Spinal Cord Injury, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a prospective cohort study designed to assess the diagnostic and prognostic potential of biomarker measurement in acute traumatic spinal cord injury (TSCI), and to examine the neuroinflammatory response to acute TSCI.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Cerebrospinal fluid and peripheral blood proteomics in Traumatic Spinal Cord Injury: A prospective pilot study.
    Wichmann TO, Kasch H, Dyrskog S, Høy K, et al · · 2022 · cited 3× · PMID 36248130 · DOI 10.1016/j.bas.2022.100906

Verify or expand the search:

Other trials of Blood samples

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injury, Acute

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03505463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing